ARCHIVES

Supreme Court Declines Appeal on Access to Experimental Therapies.

This article is from The Cancer Letter archive.

Vol. 34 No. 02 | January 18, 2008

Download PDF Visit The Full Archive

Related Articles

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982

ACS Board Tables Proposal For Accepting State, Local Funds

December 3, 1993

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003